Cancer's heterogeneity presents a significant challenge to effective treatment. While classical genetics provides crucial insights into oncogenic mutations, a deeper understanding requires integrating quantum mechanical principles governing molecular interactions.  Advances in personalized medicine leverage this understanding by focusing on the intricate quantum dynamics influencing DNA structure, protein folding, and drug-receptor interactions.  Quantum mechanical calculations, particularly density functional theory (DFT) and ab initio methods, are increasingly employed to model mutagenic processes, predict protein stability alterations due to mutations, and design targeted therapies.  These computational approaches enable the prediction of drug efficacy and toxicity with greater precision, facilitating the development of individualized treatment strategies.  Furthermore, exploring quantum entanglement in biomolecules opens avenues for novel diagnostic and therapeutic tools, such as quantum sensing for early cancer detection and quantum computing-assisted drug discovery.  Despite computational limitations, the integration of quantum mechanics is rapidly advancing our comprehension of cancer's genetic basis, paving the way for truly personalized and effective cancer therapies.  Future research should focus on developing more efficient algorithms and experimental validation to fully harness the power of quantum mechanics in the fight against cancer.